Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dienogest, OCP, decapeptyl, and fresh embryo transfer before IVF in women with endometriosis
IRCT20220609055118N1Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2022
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of dienogest and triptorelin in endometriosis and female infertility (4 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: HCG positivity, Clinical pregnancy percentage and 1 more. Started Sep 2022; status: completed.
02
Drugs
dienogesttriptorelin
03
Conditions
endometriosisfemale infertility
Beyond the preview
Go deeper on IRCT20220609055118N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220609055118N1.